Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By

Dovato (dolutegravir/lamivudine) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents age 12 and older who weigh at least 25 kilograms.

What Members Say

MHT logo These insights are based on 391 comments about Dovato from myHIVteam members. These are the experiences of a small number of people and are not meant to be medical advice.

Benefits:

  • One pill once daily feels simple to fit into a routine.
  • Many stay undetectable after switching or starting Dovato.
  • Some notice fewer side effects after switching from other HIV treatments.

Considerations:

  • Insomnia, vivid dreams, headaches, nausea, diarrhea, and anxiety can occur.
  • Weight gain or stubborn belly weight comes up as an ongoing concern.
  • Rash or itching can happen and needs prompt medical attention.

Back to top

How Dovato Works and How It’s Taken

Dovato is an antiretroviral medicine used to treat HIV-1. It contains two medicines: dolutegravir and lamivudine.

Dolutegravir blocks an enzyme called integrase. Lamivudine blocks an enzyme called reverse transcriptase. HIV-1 needs these enzymes to make more copies of itself. Blocking them helps lower the amount of HIV-1 in the body.

Doctors prescribe Dovato for adults and adolescents age 12 and older who weigh at least 25 kilograms and have not taken HIV medicine before.

It may also replace a current HIV treatment in people who:

  • Have an HIV-1 RNA level below 50 copies per milliliter
  • Are taking a stable HIV treatment
  • Have no history of treatment failure
  • Have no known resistance to dolutegravir or lamivudine

HIV-1 is the virus that causes acquired immune deficiency syndrome (AIDS).

Dovato is a tablet taken by mouth once daily. It may be taken with or without food.

Typical Dosing for HIV

The recommended dose is one Dovato tablet once daily.

Each tablet contains 50 milligrams of dolutegravir and 300 milligrams of lamivudine.

When Dovato is taken with carbamazepine or rifampin, an additional 50-milligram dolutegravir tablet should be taken about 12 hours apart from the Dovato dose.

This information is based on prescribing information, but your healthcare provider may tailor your treatment plan. Always follow their guidance.

Back to top

Top Advice From Members on Dovato

MHT logo These insights are based on 391 comments about Dovato from myHIVteam members.

Members who use Dovato often say that routines, lab follow-up, and open conversations with their HIV care team matter most. Many also suggest paying close attention to side effects, especially after switching from another HIV treatment, because experiences can vary a lot from person to person.

  • 1

    Take Dovato every day at a consistent time.
    “The most important thing is to take your meds at the same time every day. That’s why I take mine as soon as I wake up. Consistency is very important.”

  • 2

    Get blood work when your doctor recommends it.
    “I usually have bloodwork every three to six months as I have been stable and undetectable on my medications for many years now.”

  • 3

    Talk with your doctor about other medicines and interactions.
    “I take several vitamins and herbs. It is very important to check with your doctor to make sure they are safe to take with Dovato.”

Connect with others who understand life with HIV. Join myHIVteam for free.

Back to top

Dovato Side Effects

In clinical studies of Dovato, the most common side effects were:

  • Headache
  • Nausea
  • Diarrhea
  • Insomnia (trouble sleeping)
  • Fatigue (tiredness)
  • Anxiety

Serious Side Effects and Warnings

Dovato can cause serious side effects that may require immediate medical attention. These include:

  • Hepatitis B flare-up after stopping Dovato — Worsening hepatitis B virus (HBV) infection can cause serious liver problems in people who have both HIV-1 and hepatitis B.
  • Severe allergic reaction — Hypersensitivity reactions can include rash, fever, feeling very ill, swelling, trouble breathing, or liver injury.
  • Hepatotoxicity (Liver problems) — Liver injury may be more likely in people who also have hepatitis B or hepatitis C.
  • Lactic acidosis with enlarged fatty liver — A rare but serious buildup of lactic acid in the blood with liver swelling and fat can occur.
  • Immune reconstitution syndrome — Immune system changes after starting HIV treatment can uncover hidden infections or trigger autoimmune problems.

Get medical help right away if you think you are having a serious reaction.

Back to top

How To Save on Dovato

ViiV Healthcare, the manufacturer of Dovato, offers the ViiVConnect Savings Card. Eligible people with commercial insurance may pay as little as $0 per prescription fill.

The ViiVConnect Savings Card also offers reimbursement for eligible people whose pharmacy is unable to process the savings card at the time of purchase.

To learn more, visit the ViiVConnect Savings Card website or call 866-279-4705.

Back to top

What To Know Before Taking Dovato

Before starting Dovato, your doctor will test you for HBV infection.

Before you take Dovato tell your doctor if you:

  • Have or have had liver problems, including hepatitis B or hepatitis C
  • Have kidney problems
  • Are pregnant or plan to become pregnant
  • Are breastfeeding or plan to breastfeed
  • Have any allergies to dolutegravir/lamivudine or any ingredients in Dovato

Tell your doctor about all medicines you take, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements.

Do not take Dovato if you:

  • Have ever had an allergic reaction to dolutegravir, lamivudine, or any ingredients in Dovato
  • Take dofetilide

Do not stop taking Dovato or let your supply run out without speaking with your healthcare provider. The amount of virus in your blood may increase, and the virus may become harder to treat.

If you miss a dose, take it as soon as you remember. Do not take two doses at the same time or take more than your prescribed dose.

If you are pregnant, planning to become pregnant, or breastfeeding while taking Dovato, talk with your doctor about the risks and benefits.

A pregnancy exposure registry monitors pregnancy outcomes in people exposed to Dovato. Healthcare providers can register pregnancies by visiting the Antiretroviral Pregnancy Registry or calling 800-258-4263.

Talk with your healthcare provider about breastfeeding. Possible risks include:

  • Passing HIV-1 to a baby who does not have HIV-1
  • Making HIV-1 harder to treat in a baby who has HIV-1
  • Causing side effects in a breastfed baby

Back to top

Community FAQs

These answers are fact-checked by our editorial staff.

How effective is Dovato for HIV?

In adults starting HIV treatment for the first time, 91 percent of people taking dolutegravir plus lamivudine had their HIV reduced to below 50 copies per milliliter by week 48. This compared with 93 percent of people taking dolutegravir plus tenofovir disoproxil fumarate/emtricitabine.

By week 144, the rates were 82 percent and 84 percent. Both groups also had similar increases in CD4-positive cells, which are immune cells that help the body fight infections.

In adults whose HIV-1 was already controlled and who switched to Dovato, fewer than 1 percent had the virus rise to 50 copies per milliliter or higher at week 48. At week 144, 86 percent still had HIV-1 levels below 50 copies per milliliter.

How long does Dovato take to work for HIV?

The studies measured results at set follow-up visits. They did not give one exact time when Dovato starts working.

In adults starting treatment, 91 percent had HIV-1 RNA below 50 copies per milliliter by week 48. In adolescents age 12 to younger than 18 years, 87 percent reached this level by week 48.

Can Dovato cause weight gain in people taking it for HIV?

Yes. In one clinical trial, weight gain was reported in 3 percent of adults who switched to Dovato.

Weight gain has also been reported after Dovato was approved. Changes in where body fat builds up have also been reported after approval.

Back to top

More from myHIVteam on Dovato (Dolutegravir/Lamivudine) for HIV

More resources from myHIVteam that mention Dovato

Join to see what patients are asking about Dovato

Thank you for subscribing!

Become a member to get even more